Skip to main content

Routine Clinical Laboratory Measures Are Not Biomarkers of Long COVID

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 13, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 13, 2024 -- Routine clinical laboratory values do not serve as biomarkers for postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), according to a study published online Aug. 13 in the Annals of Internal Medicine.

Kristine M. Erlandson, M.D., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues examined clinical laboratory markers of SARS-CoV-2 and PASC. Differences in mean laboratory measures were assessed by prior infection and PASC index in propensity score-weighted linear regression models. Participants included 10,094 adults from 83 sites with or without SARS-CoV-2 infection with a study visit and laboratory measures six months after the index date.

Of the participants, 8,746 had prior SARS-CoV-2 infection and 1,348 were uninfected; 1,880 had a PASC index of 12 or higher and 3,351 had a PASC index of 0. The researchers found that participants with prior infection had a lower mean platelet count than those without known prior infection after propensity score adjustment, and they had a higher mean hemoglobin A1c (HbA1c) level and urinary albumin-creatinine ratio, with the differences of modest clinical significance. After exclusion of patients with preexisting diabetes, the difference in HbA1c levels was attenuated. No meaningful differences were seen in mean laboratory values between those with a PASC index of 12 or higher versus 0 among participants with prior infection.

"Understanding the basic biological underpinnings of persistent symptoms after SARS-CoV-2 infection will likely require a rigorous focus on investigations beyond routine clinical laboratory studies (for example, transcriptomics, proteomics, metabolomics) to identify novel biomarkers," the authors write.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections

WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...

AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors

TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.